Attached files
file | filename |
---|---|
S-1/A - FORM S1/A AMENDMENT NUMBER 1 - Elite Performance Holding Corp | elites1a_s1z.htm |
ORIGINAL RESEARCH
New insights on effects of a dietary supplement on
oxidative and nitrosative stress in humans
Boris V. Nemzer1,2 , Nelli Fink3 & Bruno Fink3
1VDF FutureCeuticals Inc., 2692 N State Rt. 1-17, Momence, Illinois, 60954
2University of Illinois at Urbana-Champaign, 1201 W. Gregory Dr, Urbana, Illinois, 61801
3Noxygen Science Transfer & Diagnostics GmbH, Lindenmatte 42, 79215, Elzach, Germany
Keywords
Abstract
Dietary supplement, EPR, inflammatory
response, nitric oxide, oxidative stress, RONS,
The research community is generally agreed that maintenance of healthy levels
SPECTRATM, vitality test
of free radicals and related oxidants are important for good health. However,
utilization of the redox stress hypothesis can provide us with concrete nutri-
Correspondence
tional targets in order to better support and maintain optimal health. Follow-
Boris V. Nemzer, Department of Food
ing this hypothesis we performed a crossover, double-blind, placebo-controlled,
Science and Human Nutrition, University of
single-dose study on the effects of SPECTRATM, a dietary supplement, on oxida-
Illinois at Urbana-Champaign and
FutureCeuticals Inc., 2692 N State Rt. 1-17,
tive stress markers (OSM) in human participants (n = 22). The measurement
Momence, IL 60954. Tel: +1-815-507-1427;
of OSM (ex vivo intra- and extracellular formation of reactive oxygen species
Fax: +1-815-550-0013;
(ROS, O *
2 , H2O2 , OH*) in whole blood, respiratory activity of blood cells, as
E-mail: bnemzer@futureceuticals.com
well as mitochondrial-dependent ROS formation, and respiratory activity), was
performed using EPR spectrometer nOxyscan, spin probe CMH, and oxygen
Funding Information
label NOX-15.1, respectively. Furthermore, we investigated the ability of SPEC-
This study was supported by VDF
TRATM to modulate ex vivo cellular inflammatory responses induced by stimu-
FutureCeuticals, Inc.
lation with exogenous TNF-a and also followed changes in bioavailable NO
Received: 15 July 2014; Revised: 1
concentrations. In this clinical study, we demonstrated that administration of
September 2014; Accepted: 2 September
SPECTRATM resulted in statistically significant long-term inhibition of mito-
2014
chondrial and cellular ROS generation by as much as 17% as well as 3.5-times
inhibition in extracellular NADPH system-dependent generation of O *
2 , and
Food Science & Nutrition 2014; 2(6): 828
nearly complete inhibition of extracellular H2O2 formation. This was reflected
839
in more than two times inhibition of ex vivo cellular inflammatory response
and also increases in bioavailable NO concentration. For the first time, we have
doi: 10.1002/fsn3.178
measured synergetic, biological effects of a natural supplement on changes in
OSM and cellular metabolic activity. The unique design and activity of the
plant-based natural supplement, in combination with the newly developed and
extended Vitality test, demonstrates the potential of using dietary supplements
to modulate OSM and also opens the door to future research into the use of
natural supplements for supporting optimal health.
Introduction
eficial and harmful effects caused by reactive oxygen and
nitrogen species (RONS) is an important aspect of living
During the last four decades, the research community has
organisms. Emerging research suggests that this balance
generally agreed that a dynamic, appropriately reactive,
may be achieved by a mechanism called redox regula-
and healthy balance between levels of free radicals and
tion. This theory contends that the process of redox reg-
levels of related oxidants is important for optimal
ulation protects living organisms from various oxidative
health. Imbalances of free radicals, and potentially
stresses and maintains redox homeostasis by controlling
unhealthy levels of oxidants versus antioxidants, are col-
the redox status in vivo (Droge€ 2002). An exciting discov-
lectively defined by the scientific community as oxidative
ery (Sohal and Orr 2012) has refocused and refined this
and nitrosative stress. The delicate balance between ben-
theory into the redox stress hypothesis of aging. In this
828
ª 2014 VDF FutureCeuticals, Inc. Food Science & Nutrition published by Wiley Periodicals, Inc. This is an open access article under the terms of
the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited.
B. V. Nemzer et al.
New Insights on Effects of a Dietary Supplement
new view, aging is the result of functional losses that are
these weaknesses, Noxygen Science Transfer & Diagnostics
primarily caused by a progressive pro-oxidizing shift in
GmbH (Elzach, Germany) designed a bench-top EPR
the redox status of cells and tissues. This in turn leads to
spectrometer nOxyscan. These advances in instrumenta-
the overoxidation of redox-sensitive protein thiols and
tion provided us with an opportunity to perform a pilot
the consequent disruption of normal cellular functions.
study to investigate the bioactivity of a nutritional supple-
The redox stress hypothesis is based upon the status of
ment SPECTRATM, a formulation consisting of high anti-
the redox buffers of cells, tissue, and organisms. Accord-
oxidant activity fruit, vegetable concentrates, and herbal
ing to this theory, many of the components of our redox
extracts, manufactured by FutureCeuticals, Inc. (Mo-
buffers are fundamental species of our antioxidant net-
mence, IL) and standardized to a minimum of total anti-
work. Just as it is essential to maintain our pH buffers,
oxidant capacity (TAC) as measured by a series of oxygen
we must also maintain a healthy, and appropriately
radical absorbance capacity (ORAC)based assays col-
reduced oxidative state for our redox buffers. The effect
lected under the name ORAC 5.0, including ORAC,
of reactive oxygen species (ROS) that may cause potential
HORAC, NORAC, SORAC, and SOAC (Mullen et al.
biological damage has been termed oxidative stress and
2011).
the effect of reactive nitrogen species (RNS) has been
termed nitrosative stress (Kovacic and Jacintho 2001;
Valko et al. 2001; Ridnour et al. 2005). This model pre-
Material and Methods
sents us with concrete targets for potential nutritional
intervention in order to maintain optimal health and sup-
Natural SPECTRATM total ORAC 5.0 blend
port healthy aging and provides a means to investigate
This full-spectrum antioxidant activity product is a pro-
the direct effects of nutritional materials on biomarkers of
prietary combination of fruit, vegetable, and herb extracts
significance for healthy aging (Broedbaek et al. 2013).
and concentrates: broccoli powder and broccoli sprouts
The healthy balance in the body is comprised of four
concentrate, onion extract, tomato concentrate, dried car-
components:
rot, spinach, kale concentrate, brussel sprout concentrate,
1 An appropriately modulated, healthy flux of free radi-
whole coffee fruits extract, acerola extract, camu camu
cals and oxidants.
powder, acai berry concentrate, mangosteen concentrate,
2 An appropriate level of antioxidants coupled with fully
green tea extract, apple extract, turmeric concentrate, gar-
functional systems to recycle these antioxidants.
lic, basil concentrate, oregano, cinnamon concentrate,
3 Robust nutritional support that helps to maintain opti-
elderberry concentrate, blackcurrant extract, blueberry
mal levels of supportive antioxidants and cofactors.
extract, sweet cherry powder, blackberry powder, choke-
4 Fully functioning enzyme systems that repair or
berry, raspberry powder, and bilberry extract. The ORAC
recycle and replace damaged cellular materials, for
5.0 assay measures antioxidant activities against hydroxyl,
example, DNA, RNA, enzymes, proteins, and endoge-
peroxyl, peroxynitrite, singlet oxygen, and superoxide
nous redox molecules (glutathione, vitamin C, vitamin
anion. SPECTRATM is standardized to minimum 40,000
E etc.).
lmol trolox equivalent (TE) per gram of ORAC 5.0 assay
Electron paramagnetic resonance (EPR) spectroscopy is
(Nemzer et al. 2014).
a technique that is recognized in the scientific community
as a gold standard methodology (Dikalov et al. 2007) for
direct observation ex vivo or in vivo of the formation of
Sample preparation for antioxidant
RONS. Recently, we also published observation of imag-
measurements
ing of ROS (Ji et al. 2012) performed in living animals. It
The sample preparation was conducted following the
has been shown that for studies of intact tissues and cells,
previous protocol (Mullen et al. 2011; Nemzer et al.
the cyclic hydroxylamine spin probes offer a distinct
2014). Approximately 20 mg of SPECTRATM was
advantage over nitrone spin traps to measure the produc-
extracted with 20 mL of ethanol/water (70:30 v/v) for
tion of superoxide anion and other radicals due to the
1 h at room temperature on an orbital shaker. After
fact that they yield very stable products and strong EPR
centrifugation at 4164g, the supernatant of the extract
signals. Cyclic hydroxylamine spin probes such as 1-
was subjected to the TAC assay. The TAC includes the
hydroxy-3-carboxy-pyrrolidine and 1-hydroxy-3-methoxy-
determination of radical scavenging capacities against
carbonyl-2.2.5.5-tetramethylpyrrolidine are very effective
five free radicals, namely, peroxyl, hydroxyl, peroxyni-
scavengers of superoxide radicals (Dikalov et al. 1998;
trite, superoxide anions, and singlet oxygen radicals. All
Fink et al. 2000; Dikalov and Fink 2005). The major
results were expressed as Trolox equivalent per gram
weaknesses of EPR are: (1) it is expensive and (2) it
(lmol TE/g) and the TAC was the sum of the five indi-
requires a substantial amount of space. To overcome
vidual results.
ª 2014 VDF FutureCeuticals, Inc. Food Science & Nutrition published by Wiley Periodicals, Inc.
829
New Insights on Effects of a Dietary Supplement
B. V. Nemzer et al.
Peroxyl radical scavenging capacity (ORAC
Superoxide anion scavenging assay (SORAC
assay)
assay)
The ORAC assay was measured according to a previous
The SORAC assay was conducted following the previously
report by Ou et al. (2002) and Huang et al. (2002) with
described method by Zhang et al. (2009). Hydroethidine
modification. The FL600 microplate fluorescence reader
(HE) was used to measure O *
2 scavenging capacity. The
(Bio-Tek Instruments, Inc., Winooski, VT) was used with
mixture of xanthine and xanthine oxidase was used to
an excitation wavelength of 485 (20 nm) and emission
generate O *
2 radicals. Nonfluorescent HE was oxidized
wavelength of 530 (25 nm). About 2,20-Azobis(2-amidi-
by O *
2 to form a species of unknown structure that emits
nopropane) dihydrochloride (AAPH) was used to generate
fluorescence signal at 586 nm. Addition of superoxide
peroxyl radical. Fluorescein (FL) was used as a fluorescent
dismutase (SOD) inhibits the HE oxidation.
probe to indicate the extent of damage from its reaction
with the peroxyl radical. The antioxidant effect was mea-
sured by comparing the fluorescence time/intensity area
Singlet oxygen scavenging assay (SOAC
under the curve of the sample to that of a control with no
assay)
antioxidant. Trolox was prepared as the standard solution.
The SOAC assay was modified based on the previously
Fluorescence was measured every min for up to 35 min.
described method by Zhao et al. (2003). HE was used as
a probe to measure singlet oxygen. The mixture of H2O2
Hydroxyl radical scavenging capacity
and MoO 2*
4 was used to generate singlet oxygen. About
(HORAC assay)
40 lmol/L solution of HE, 2.635 mmol/L Na2MoO4, and
13.125 mmol/L H2O2 working solutions were prepared in
The assay was modified according to a report by Ou et al.
N,N-dimethylacetamide (DMA). HE solution (125 lL)
(2002). Fluorescein (FL) was used as a fluorescent probe.
was added to a well followed by addition of 25 l L of
The antioxidant effect was measured by comparing the
2.635 mmol/L Na2MoO4 and 25 lL of 13.125 mmol/L
fluorescence time/intensity area under the curve of the
H2O2, respectively. Singlet oxygen scavenging was
sample to that of a control with no antioxidant. Trolox
measured in a fluorescence reader with an excitation
was used as the standard for calibration.
wavelength of 530 nm and emission wavelength of
620 nm.
Peroxynitrite scavenging capacity (NORAC
assay)
Study design
Peroxynitrite (ONOO*) scavenging values were deter-
Twenty-two healthy participants (13 females, nine males)
mined by monitoring the oxidation of DHR-123 based
with a mean age of 41 years (range 2159), and a mean
on a protocol by Chung et al. (2001). A stock solution of
body weight of 77 kg (range 6292) entered this study.
DHR-123 (5 mM) was prepared in dimethylformamide,
The study was carried out according to the recommenda-
purged with nitrogen, and stored at *80°C. A working
tions for clinical trials in humans, declaration of Helsinki.
solution of DHR-123 (final concentration, fc, 5 lmol/L)
All subjects were in generally good health as confirmed by
diluted from the stock solution was placed on ice in the
physical examination and laboratory tests investigating
dark before the experiment started. The reaction buffer
lipid, carbohydrate, and inflammatory profiles (see sum-
consisting of 90 mmol/L sodium chloride, 50 mmol/L
mary Table in section Results). The study was performed
sodium phosphate (pH 7.4), and 5 mmol/L potassium
in double-blind, single-dose, crossover, placebo-controlled
chloride with 100 lmol/L (fc) diethylenetriaminepenta-
fashion. Generally accepted contraindications to physical
acetic acid (DTPA) was purged with nitrogen and placed
exercise; previously diagnosed type 1 and 2 diabetes; fast-
on ice before use. ONOO* scavenging was measured in a
ing glucose >110; C-reactive proteins >3; liver and kidney
fluorescence reader with an excitation wavelength of 485
impairments; psychiatric disorders, other disorders of
(20 nm) and emission wavelength of 530 (25 nm). Five
acute or chronic nature (gastrointestinal, pulmonary,
minutes after treating with or without SIN-1 (fc 10 lmol/
renal, cardiac, neurological, or psychiatric disorders),
L) or authentic ONOO* (fc 10 lmol/L) in 0.3 N sodium
known allergies to foods or their ingredients, use of
hydroxide, the background and final fluorescent signals
weight reducing preparations or appetite suppressants,
were measured. Oxidation of DHR-123 increased by
b-blockers, ACE inhibitors, statins, insulin, NSAID, pain
decomposition of SIN-1 gradually, whereas authentic
medications, participation in a clinical study within the
ONOO* rapidly oxidized DHR-123 with its final fluores-
last 30 days prior to the beginning of this study or during
cent signal being stable over time.
this study as well as intake of vitamins/dietary
830
ª 2014 VDF FutureCeuticals, Inc. Food Science & Nutrition published by Wiley Periodicals, Inc.
B. V. Nemzer et al.
New Insights on Effects of a Dietary Supplement
supplements 2 weeks prior to the start or during the trial
were exclusion criteria for participation in this study.
Cellular TNF-a response assay
In addition to H2O2 detection, Noxygen Science Transfer
Study protocol
& Diagnostics GmbH has developed and validated an ex
vivo cellular inflammatory response assay. Application of
All 22 participants were separated into the two groups
this assay provides results describing changes in ROS gen-
and were matched for age and gender to the best practi-
eration by blood cells after stimulation with external
cal and/or possible degree. They received an emotional
(nonendogenous) TNF-a. TNF-a had previously been
and general health evaluation questionnaire. At day 0
reported to be a key factor of inflammation (Feuerstein
(requirement), blood was drawn after 12 h of fasting per-
et al. 1994). The assay was performed using blood sam-
iod for performance of laboratory tests and for analysis
ples from each of the study subjects (20 lL). Samples
of glucose as well as extended Vitality test. Standardized
were not analyzed for changes in TNF-a concentration,
breakfast (one bread roll with a glass of water) was
but rather for changes in downstream effects resulting
served at day 0. Standardized breakfast was also served
from exogenous TNF-a challenge. Samples were mixed
on day 1 and day 2 along with placebo or SPECTRATM
with 20 lL solution of human TNF-a (#T6674;
100 mg capsule, respectively. Capillary blood was col-
Sigma-Aldrich, St. Louis, MO) and spin probe 1-
lected for performance of extended Vitality test at the
Hydroxy-4-phosphono-oxy-2,2,6,6-tetramethyl-piperidine
time 0, and also immediately prior to the standardized
(PPH, Noxygen GmbH, # NOX-4.1) solved in Krebs He-
breakfast on day 0, and prior to the standardized break-
pes buffer (20 mmol/L, pH 7.4). Final concentrations
fast and treatment on days 1 and 2, as well as after 1, 2,
were 40 ng/mL TNF-a and 500 lmol/L PPH, respectively.
and 3 h after capsule administration. Cardiovascular
The mixture filled in a teflon, oxygen permeable capillary
parameters and blood pressure were recorded using a
tube was placed in the resonator of EPR spectrometer
Dinamap XL (Johnson & Johnson Medical GmbH,
(nOxyscan, Noxygen GmbH) equipped with a tempera-
Norderstedt, Germany).
ture and gas controller BIO-III (TGC, Noxygen GmbH)
for monitoring of EPR signal within 60 min.
Detection of ROS in human blood
The TGC setting was as follows: temperature 37°C,
10 mmHg pressure, and 4% oxygen concentration. EPR
The extended Vitality test that we employed in this
settings: center field: 3472 G; sweep width: 60 G; static
pilot study was developed by Noxygen Science Transfer &
field: 3458 G; frequency: 9.76 GHz; attenuation: 4.0 dB;
Diagnostics GmbH (Elzach, Germany). The principle of
microwave power: 20 mW; gain: 1 9 103; modulation
the method is based upon the monitoring of ESR signal
frequency: 86.00 kHz; modulation amplitude: 2.2 G; time
of spin probe (CMH, 200 lmol/L) oxidation that has
constant: 40.96 msec; conversion time: 10.24 msec; sweep
been mixed with freshly drawn blood. During the pro-
time: 5.24 sec; number of scans: 10; number of points:
cess, the blood cells stand under the original physiological
46; experimental time: 60 min. A kinetic curve slope
environment (t = 37°C, pO2 = 110 mmHg) and remain
(EPR signal amplitude vs. time) for the 60 min was inte-
surrounded by blood plasma that releases biologically
grated and expressed as formation of ROS lmol/L per
available ROS that interacts in intracellular and extracel-
min.
lular space with CMH to form a stable radical CM°
(Bassenge et al. 1998; Fink et al. 2000; Mrakic-Sposta
et al. 2012). Addition of oxygen-sensitive label (NOX-
Bioavailable NO concentration assay
15.15 lmol/L) to the blood sample allows us to monitor
Analysis of circulating NO concentration in human
oxygen concentrations and cellular as well as mitochon-
blood, second key signaling molecule of vascular physiol-
drial oxygen consumption (Bobko et al. 2009; Komarov
ogy and an in vivo antioxidant, was performed in previ-
et al. 2012). Bench-top EPR spectrometer nOxyscan
ous studies (Dikalov and Fink 2005; Pisaneschi et al.
was used with the following settings: center field:
2012).
g = 2.011, sweep width: 60 G, frequency: 9.76 GHz,
power: 20 mW, gain: 1 9 103, modulation amplitude:
1.2 G, sweep time: 5.24 sec, number of scans: 10, number
Chemicals
of points: 512, total experimental time: 5 min. Calibra-
The spin probes 1-hydroxy-3-methoxycarbonyl-2.2.5.5-te-
tion of EPR signal was performed using calibration solu-
tramethylpyrrolidine (CMH), 1-hydroxy-4-phosphono-
tion with standard concentration of CM° (10 lmol/L) or
oxy-2.2.6, 6-tetramethylpiperidine (PPH), the metal chela-
oxygen label NOX-063 (5 lmol/L) filled in to 50 lL glass
tors defferoxamine (DF), and diethyldithiocarbamate
capillary.
(DETC). KrebsHepes buffer (KHB), and the oxygen label
ª 2014 VDF FutureCeuticals, Inc. Food Science & Nutrition published by Wiley Periodicals, Inc.
831
New Insights on Effects of a Dietary Supplement
B. V. Nemzer et al.
NOX-15.1 were obtained from Noxygen Science Transfer
pressure 123 ♥ 4 mmHg, did not exceed the values of
& Diagnostics, CuZn superoxide dismutase (SOD) was
healthy persons. Mean values of laboratory parameters
obtained from SigmaAldrich (St. Louis, MO). All other
from all study participants at day 0 are depicted below
chemicals and reagents used were of analytical grade and
in the Table 2.
were purchased from SigmaAldrich unless otherwise
Detection of ROS was performed with extended Vitality
specified.
test protocol which allows analysis for:
1 total(extracellular/intracellular) generation of ROS/
Statistical analysis
cellular oxygen consumption;
2 extracellulargeneration of O *
2 /cellular oxygen con-
All statistical analyses were performed with the SigmaPlot
sumption by addition of SOD (50 U/mL);
11.0 (Chicago, IL). P value was calculated using one-way
3 extracellulargeneration of H2O2/cellular oxygen
ANOVA with Holm-Sidak method, and P < 0.05 was
consumption by addition of catalase (50 U/mL);
considered as statistically significant.
4 mitochondrialgeneration of mitochondrial O *
2 /
mitochondrial oxygen consumption by addition of
Results
Antimycin A (10 lmol/L).
As Figure 1 immediately below demonstrates, at
The biological active phytochemical compounds, vita-
60 min after 100 mg single-dose SPECTRATM administra-
mins, minerals, and TAC per 100 mg serving size of the
tion we observed a significant decrease in total generation
SPECTRATM are summarized in Table 1.
of ROS/metabolic activity of blood cells in human volun-
According to the study protocol, we recruited nine
teers. These effects persisted for another 2 h followed by a
male and 13 female generally healthy participants between
significant trend toward baseline 3 h after administration.
the ages of 21 and 59 years and with body weight of
77.4 ♥ 10.2 kg and BMI of 26.3 ♥ 2.2 (typical for an
industrial country like Germany). Cardiovascular parame-
Table 2. Laboratory parametershemogram, metabolic-, inflamma-
ters such as heart rate 67 ♥ 8 bit/min, and blood
tory-, and lipid-profile.
Inflammatory
Table 1. Biological active compounds and TAC for SPECTRATM per
Hemogram
parameters
serving size 100 mg.
Hemoglobin
14.1 ♥ 1.3
Leukocytes (tsd/lL)
5.7 ♥ 1.6
Units
Result
(g/dL)
Erythrocytes
4.7 ♥ 0.4
Neutrophils
3.0 ♥ 1.0
Phytochemical compound
(mio/lL)
absolute (tsd/lL)
Glucosinolates
mg
0.1
Hematocrit (%)
40.9 ♥ 3.6
Neutrophils (%)
52.9 ♥ 7.5
Quercetin
mg
10.8
MCH (pg)
30.1 ♥ 1.2
Eosinophil
0.15 ♥ 0.10
Lycopene
l
g
43
absolute (tsd/lL)
Chlorogenic acids
mg
6.7
MCV (fL)
87.1 ♥ 3.0
Eosinophil (%)
2.5 ♥ 1.2
Vitamin C
mg
1.2
MCHC (g/dL)
34.5 ♥ 0.8
Lymphocytes
2.0 ♥ 0.6
Catechins
mg
10.3
absolute (tsd/lL)
Allicin
l
g
10Immature
0.3 ♥ 0.1
Lymphocytes (%)
35.0 ♥ 6.9
Alliin
l
g
20granulocytes
Anthocyanins
mg
0.5
(%)
Vitamin E
lg
13.4
Thrombocytes
218.0 ♥ 52.2 CRP (mg/L)
2.7 ♥ 2.3
Beta-carotene
lg
36.4
(tsd/lL)
Folate
lg
1.2
Vitamin K
lg
3.1
Calcium
mg
0.77
Metabolic-profile
Lipid-profile
Magnesium
mg
0.53
Insulin (mU/L)
10.6 ♥ 6.5
Triglyceride/neutral 124.8 ♥ 72.3
Potassium
mg
4.3
fat (mg/dL)
Activity against individual radicals
Glucose in
90.7 ♥ 10.2 Cholesterol
217.7 ♥ 54.7
Activity against peroxyl radicals
lmol TE
1070
serum (mg/dL)
Activity against hydroxyl radicals
lmol TE
1511
Glucose/whole
73.2 ♥ 9.7
HDL cholesterol
51.7 ♥ 22.6
Activity against peroxynitrite
lmol TE
110
blood (mg/dL)
(mg/dL)
Activity against superoxide anion
lmol TE
1337
Homa-index
2.3 ♥ 1.7
VLDL cholesterol
24.2 ♥ 14.4
Activity against singlet oxygen
lmol TE
417
(mg/dL)
(mg/dL)
Total activity
lmol TE
4445
LDL cholesterol
141.8 ♥ 40.1
(mg/dL)
TAC, total antioxidant capacity.
832
ª 2014 VDF FutureCeuticals, Inc. Food Science & Nutrition published by Wiley Periodicals, Inc.
B. V. Nemzer et al.
New Insights on Effects of a Dietary Supplement
Figure 1. Effect of SPECTRATM
Figure 2. Effect of SPECTRATM on cellular oxygen consumption of
on cellular “total” ROS generation/
blood cells collected from human volunteers. Oxygen consumption
metabolic activity in human participants. Detection of reactive oxygen
analysis was performed with the same blood samples using spin label
species was performed using spin probe CMH (200 lmol/L) and
NOX-15.1 (5 lmol/L) and bench-top EPR spectrometer nOxyscan in 22
bench-top EPR spectrometer nOxyscan in 22 generally healthy, fasted
generally healthy, fasted (minimum 12 h) participants. Blue columns
(minimum 12 h) participants. Blue columns (control): prior to and 60,
(control): prior to and 60, 120, 180 min after consumption of
120, 180 min after consumption of standard breakfast (bread roll
standard breakfast (bread roll with glass of water); red columns
with glass of water); red columns (placebo): after consumption of
(placebo): after consumption of standard breakfast and placebo
standard breakfast and placebo capsule; and green columns
(SPECTRATM): after consumption of standard breakfast and SPECTRATM
capsule; and Green columns (SPECTRATM): after consumption of
standard breakfast and SPECTRATM capsule. Observation of oxygen
capsule. For EPR settings, please refer to material and methods. Data
concentration changes was possible due to optimization of
are mean (n = 22) ♥ SEM, *P < 0.05 versus value “before.” CMH, 1-
modulation amplitude 1 G, which makes it possible to follow EPR
hydroxy-3-methoxycarbonyl-2.2.5.5-tetramethylpyrrolidine; EPR, electron
amplitude of separately appearing CM-radical and oxygen label EPR
paramagnetic resonance.
lines. Data are mean ♥ SEM (n = 22), *P < 0.05 versus value
“before.” EPR, electron paramagnetic resonance.
Under pathological conditions, increased oxidative stress
itself can alter oxygen levels. Changes in oxygen levels
may subsequently affect mitochondrial oxygen consump-
tion. In order to circumvent this problem, EPR method
0.20
Control Placebo SpectraTM
has been developed for measuring superoxide and oxygen
consumption in mitochondrial respiratory complexes
0.15
using the oxygen labels such as NOX-15.1 (Mariappan
et al. 2009). By using a gas controller and nontoxic spin
label NOX-15.1, we were able to measure oxygen con-
0.10
sumption simultaneously during detection of ROS. The
merit of this method is that it allows us to measure
0.05
superoxide production and oxygen consumption in paral-
lel using the same incubation medium and substrate con-
centration in each blood sample. Simultaneously to
0.00
Before
1 h after
2 h after
3 h after
changes in levels of ROS, we observed a significant
increase in cellular oxygen consumption (Fig. 2) as well
Figure 3. Influence of SPECTRATM on “mitochondrial” oxygen
as mitochondrial oxygen consumption (Fig. 3) after 1 h
consumption of blood cells collected from human participants.
of SPECTRATM
Mitochondrial oxygen consumption was performed in the same blood
ingestion. These levels continued to be
samples using spin label NOX-15.1 (5 lmol/L) and bench-top EPR
slightly elevated during the next 2 h. These findings sug-
spectrometer nOxyscan after addition of Antimycin A (10 lmol/L)
gest optimization of redox balances and optimization of
prior to and at 60, 120, 180 min after consumption of standard
respiratory activity of mitochondria factors that are
breakfast (bread roll with glass of water). Blue columns (control): prior
important for healthy aging (Dikalova et al. 2010; Naza-
to and 60, 120, 180 min after consumption of standard breakfast
rewicz et al. 2013). The same pattern as cellular ROS gen-
(bread roll with glass of water); red columns (placebo): after
eration was recognized in the mitochondrial generation of
consumption of standard breakfast and placebo capsule; and green
ROS after SPECTRATM
columns (SPECTRATM): after consumption of standard breakfast and
administration. It decreased signif-
SPECTRATM capsule. The values of oxygen consumption were
icantly after 1 h and continued to decrease for the next
calculated as delta value between “total” and “Antimycin A” sample.
2 h (Fig. 4). Although generation of ROS in the control
Data are mean ♥ SEM, P < 0.05 versus value “before.” EPR, electron
and placebo group showed nonsignificant tendencies
paramagnetic resonance.
ª 2014 VDF FutureCeuticals, Inc. Food Science & Nutrition published by Wiley Periodicals, Inc.
833
New Insights on Effects of a Dietary Supplement
B. V. Nemzer et al.
0.60
Control Placebo SpectraTM
1.25
Control Placebo SpectraTM
0.50
1.10
0.40
0.95
0.30
0.20
0.80
Before
1 h after
2 h after
3 h after
Before
1 h after
2 h after
3 h after
Figure 4. Effect of SPECTRATM on “mitochondrial” ROS generation
Figure 5. Influence of SPECTRATM on “extracellular” superoxide
in blood cells collected from human volunteers. Detection of
(O *
2 ) formation in blood cells collected from human volunteers.
mitochondrial ROS generation was performed using spin probe CMH
Superoxide formation was analyzed in human blood using EPR
(200 lmol/L) and bench-top EPR spectrometer nOxyscan after
spectrometer nOxyscan, spin probe CMH (200 lmol/L) after addition
addition of Antimycin A (10 lmol/L) in the blood samples taken prior
of SOD (50 U/mL) in the blood samples taken prior to and at 60, 120,
to and at 60, 120, 180 min after consumption of standard breakfast
180 min after consumption of standard breakfast (bread roll with
(bread roll with glass of water). Blue columns (control): prior to and
glass of water). Blue columns (control): prior to and 60, 120, 180 min
60, 120, 180 min after consumption of standard breakfast (bread roll
after consumption of standard breakfast (bread roll with glass of
with glass of water); red columns (placebo): after consumption of
water); Red columns (placebo): after consumption of standard
standard breakfast and placebo capsule; and green columns
breakfast and placebo capsule; and Green columns (SPECTRATM):
(SPECTRATM): after consumption of standard breakfast and
after consumption of standard breakfast and SPECTRATM capsule. The
SPECTRATM capsule. The values of ROS generation were calculated
values of superoxide generation were calculated as delta value between
as delta value between “total” and “Antimycin A” sample. Data
“total” and “SOD” sample. Data are mean ♥ SEM (n = 22), *P < 0.05
are mean ♥ SEM (n = 22), *P < 0.05 versus value “before.”
versus value “before.” CMH, 1-hydroxy-3-methoxycarbonyl-2.2.5.5-
CMH, 1-hydroxy-3-methoxycarbonyl-2.2.5.5-tetramethylpyrrolidine; EPR,
tetramethylpyrrolidine; EPR, electron paramagnetic resonance.
elec-tron paramagnetic resonance; ROS, reactive oxygen species.
toward depletion of ROS formation, this is consistent
with previous observations collected from nonathletically
1.40
Control Placebo SpectraTM
trained participants (B. Fink, unpubl. data). In addition
to the decrease in total ROS generation and oxygen
consumption, the administration of a single dose of
1.20
SPECTRATM significantly inhibited generation of extracel-
lular NADPH oxidase-dependent superoxide (O *
2 , Fig. 5)
and peroxidase-dependent hydrogen peroxide (H2O2,
1.00
Fig. 6). The possibility for such regulatory effects on
NADPH-oxidases activity suggests that SPECTRATM may
help support cardiovascular health in healthy aged sub-
jects (Wyche et al. 2004; Dikalov et al. 2012). Compared
0.80
Before
1 h after
2 h after
3 h after
to the total ROS generation, the values of both super-
oxide and hydrogen peroxide generation in the control as
Figure 6. Influence of SPECTRATM on extracellular H2O2 formation in
well as in the placebo group showed nonsignificant deple-
blood cells collected from human volunteers. H2O2 formation was
analyzed in human blood using EPR spectrometer nOxyscan, spin probe
tion tendencies over the observation period.
CMH (200 lmol/L) after addition of catalase (50 U/mL) in the blood
In order to provide more robust scientific proof on
samples taken prior to and at 60, 120, 180 min after consumption of
inhibition of peroxidase activities, which are linked to
standard breakfast (bread roll with glass of water). Blue columns
inflammatory response, we performed analysis of ex vivo
(control): prior to and 60, 120, 180 min after consumption of standard
changes in cellular ROS (almost hydrogen peroxide,
breakfast (bread roll with glass of water); red columns (placebo): after
H2O2) formation after a challenge by stimulation with
consumption of standard breakfast and placebo capsule; and green
externally introduced TNFa. TNFa is recognized as one
columns (SPECTRATM): after consumption of standard breakfast and
SPECTRATM capsule. The values of H
of the key mediators of inflammation that is directly
2O2 generation were calculated as
delta value between “total” and “catalase” sample. Data are
linked to ROS generation and apoptosis. We demon-
mean ♥ SEM (n = 22), *P < 0.05 versus value “before.” CMH, 1-
strated significant inhibition of cellular response after
hydroxy-3-methoxycarbonyl-2.2.5.5-tetramethylpyrrolidine; EPR, electron
administration of SPECTRATM (Fig. 7). Another example
paramagnetic resonance.
834
ª 2014 VDF FutureCeuticals, Inc. Food Science & Nutrition published by Wiley Periodicals, Inc.
B. V. Nemzer et al.
New Insights on Effects of a Dietary Supplement
0.12
30.00
Control Placebo SpectraTM
Placebo
Spectra-TM
0.09
20.00
0.06
10.00
0.03
0.00
Figure 7. Inhibition of TNFa-induced “cellular inflammatory
Figure 8. Influence of SPECTRATM on circulating NO concentration in
response” after single dose of SPECTRATM in blood cells collected
blood of human volunteers. Bioavailable NO level was analyzed in
from human volunteers. This testing measured response of blood cells
human blood according to material and methods described by
after chemical insult by stimulation with 40 ng/mL of exogenous
protocol detection of circulating NOHb concentration in blood
human TNFa. As expected, this stimulation subsequently induced ROS
samples. Green column (placebo): 180 min after consumption of
(H2O2) formation. Levels of H2O2 in blood samples from the study
standard breakfast and placebo capsule; and Blue column
subjects were analyzed using EPR spectrometer nOxyscan,
(SPECTRATM): 180 min after consumption of standard breakfast and
nonmembrane permeable spin probe PPH (500 lmol/L). Blue column
SPECTRATM capsule. Data are mean ♥ SEM (n = 22), *P < 0.01
(control): 180 min after consumption of standard breakfast (bread roll
versus placebo.
with glass of water); red column (placebo): 180 min after
consumption of standard breakfast and placebo capsule; and Green
column (SPECTRATM): 180 minutes after consumption of standard
The previously reported cardiosupportive action of
breakfast and SPECTRATM capsule. The accumulation of oxidized PP-
quercetin, one of the major active compounds in SPEC-
radical was observed during 1 h incubation at 37C and 40 mmHg
TRATM, was described as a compound attenuating oxida-
oxygen partial pressure. Data are mean ♥ SEM (n = 22), P < 0.01
tive stress by depletion of serum and tissue MDA
versus placebo. Baseline and posttreatment levels of TNF-a were not
measured. ROS, reactive oxygen species.
(malondialdehyde) formation and moderate incrementa-
tion of antioxidant reserves (Annapurna et al. 2009). Such
cardiosupportive effects may be caused by inhibition of
of the multifaceted effect of SPECTRATM, especially in
mitochondrial ROS generation, which have been demon-
terms of potential for support of cardiovascular health, is
strated in this clinical study (Fig. 4). Possible explanation
normalization of nitrosative stress, which may be evalu-
of that mechanism was proposed by Chen et al. (2013)
ated based on analysis of bioavailable circulating NO con-
wherein it was reported that inhibition of doxorubicin-
centration in vivo (Pisaneschi et al. 2012). Detection of
dependent cardiomyocyte oxidative damage was caused
circulating NO concentration in whole blood of partici-
by uncoupling of mitochondria. Another cardiosupportive
pants after administration of SPECTRATM showed signifi-
mechanism of quercetin has been suggested in recent
cant increase in the level of NO (Fig. 8).
studies that reported the inhibitory effects of quercetin on
inducible NO synthase over TNF-a and on inflammatory
Discussion
gene expression (Wadsworth and Koop 2001; Wadsworth
et al. 2001; Boesch-Saadatmandi et al. 2011). It has been
In this pilot study, we delivered evidence expanding on
shown that these effects as well as predisposition of
the introduction of the free radical theory of aging pro-
inflammatory cascade components begin with phenotypic
posed by Harman (1956). Thereafter, in 1969, the discov-
differences in redox-enzymes such as NADPH oxidase
ery of the enzyme superoxide dismutase (SOD), provided
(Wyche et al. 2004), GSH reductase (Bailey et al. 2014),
further convincing evidence suggesting the importance of
catalase (Suvorava et al. 2005), heme oxygenase (Seo
healthy levels of free radicals in living systems (McCord
et al. 2013) and play an important role in inflammatory
and Fridovich 1969), and the possible use of nutritional
responses. In this study, we observed the modulatory
supplements to maintain optimal health by modulating
effect of SPECTRATM on increases in ROS generation
the extent of oxidative and nitrosative stress. The
brought about due to challenge with exogenous TNF-a
observed multifaceted biological effects of SPECTRATM on
(Fig. 7) as well as on preservation of bioavailable NO by
oxidative and nitrosative stress may be directly attribut-
reduction in cellular and mitochondrial ROS formation
able to the supplements biologically active compounds as
(Fig. 8).
well as substrates required for healthy function of
Tea polyphenols known as catechins are present in two
enzymes involved in redox regulation reported in Table 1.
SPECTRATM componentsgreen tea extract and apple
ª 2014 VDF FutureCeuticals, Inc. Food Science & Nutrition published by Wiley Periodicals, Inc.
835
New Insights on Effects of a Dietary Supplement
B. V. Nemzer et al.
extract. Previous studies (Yamamoto et al. 2004; Manach
to measure the influence of SPECTRATM on all four com-
et al. 2005) reported that catechins may increase the anti-
ponents of the healthy aging hypothesis. The strength
oxidant capacity of human plasma, which in turn could
of the signals generated by cyclic hydroxylamines and the
support cardiovascular health, improvement of processes
ability to use the technology to study changes that occur
associated with lipoprotein oxidation, blood aggregation,
at the level of cellular components such as mitochondria,
and changes in lipid profiles. Other studies (Imai and
vessels, cells, and human blood (Fink et al. 2000; Mrakic-
Nakachi 1995; Sesso et al. 1999; Nakachi et al. 2000; Sas-
Sposta et al. 2012) allow us to follow quantifiable biologi-
azuki et al. 2000; Sano et al. 2004; Kuriyama et al. 2006;
cal effects in healthy human subjects. CMH was adopted
Kuriyama 2008) also suggested that tea polyphenols con-
due to the fact that it is a molecule capable of diffusion
sumption may promote cardiovascular health due to acti-
in cell compartments, including mitochondria (Dikalov
vation of CuZn-SOD activity and by increasing enzyme
et al. 2011). Indeed, due to its particular physical-chemi-
expression a parameter also observed by SOD-dependent
cal properties, the CMH probe is able to cross biological
extracellular O *
2 generation (Fig. 5) in this current study.
membranes, thereby detecting ROS both in plasma and
Earlier science has suggested that dietary chlorogenic
intracellular compartments. In this way, EPR measure-
acids (CGA)the major group of coffee polyphenols
ments enable us to make relative quantitative determina-
may reduce the oxidative stress and improve nitric oxide
tions of ROS production rates in human blood samples.
bioavailability by inhibiting excessive production of reac-
Additionally, owing to its high efficiency in radical detec-
tive oxygen species in the vasculature, and lead to the
tion, CMH probe can be used at very low concentrations
attenuation of endothelial dysfunction (Ohga et al. 2009;
(0.2 mmol/L) compared to spin traps (1050 mmol/L),
Yan et al. 2013). Others reported that the initial CGA
an attribute that minimizes side-effects of the probes on
metabolite, caffeic acid, significantly increased superoxide
cell physiology. Moreover, CMH rapidly reacts and allows
dismutase, catalase, and glutathione peroxidase activity
radical detection via a single chemical reaction, while
and lowered plasma glucose concentration (Rustan et al.
other probes require at least two reactions that may cause
1997; Jung et al. 2006). CGA has also been examined in
artifacts by interaction of two byproducts (Zielonka et al.
human studies for possible effects upon blood pressure
2005).
and vasoreactivity effects (Watanabe et al. 2006).
In addition to the above-reported biological effects on
Observation of allicin showed spontaneous inhibition
oxidative and nitrosative parameters, we observed an
and TNF-a induced secretion of proinflammatory cyto-
additional effect of lowering of glucose concentrations in
kines and chemokines from intestinal epithelial cells
the participants blood (Fig. 9) that may have been asso-
(Lang et al. 2004). Allicin can permeate epithelial and red
ciated with increases of mitochondrial oxygen consump-
blood cells membranes of phospholipids bilayers, carry
tion as well as metabolic activity of cells. Such possible
out its activity intracellularly, and interact with SH groups
effect of SPECTRATM is worthy of further investigation.
(Miron et al. 2000).
Biologically active compounds as well as microele-
ments, vitamins, and enzymes in natural supplement
130
Control
Placebo
SpectraTM
SPECTRATM may participate and support the regulation
of degree from oxidative and nitrosative stress. Previous
clinical studies have reported that administration of vita-
115
min C (Bassenge et al. 1998) or vitamin E (Mah et al.
2013) in low dosages were able to inhibit/restore endothe-
lial dysfunction, a consequence of excessive oxidative
100
and nitrosative stress. Therefore, it may be possible that
components of SPECTRATM may contribute in unfolding
activity of biologically active enzymes.
Initially, the Total ORACFN assay was used to deter-
85
mine SPECTRATMs ability to modulate the in vitro anti-
oxidant scavenging capacity of five major free radicals
(peroxyl, superoxide anion, hydroxyl, singlet oxygen, and
70
peroxynitrite) that are naturally produced in the body.
Fasting
1 h after
2 h after
3 h after
This product has been standardized to deliver a total
Figure 9. Changes
in
blood
glucose
concentration
after
minimum ORACFN of 40,000 lmol TE/g. In order to
supplementation of standard breakfast with or without placebo/
confirm that SPECTRATM could exert any activity in vivo,
SPECTRATM. Data are mean ♥ SEM (n = 22), *P < 0.025 versus
we employed the extended Vitality test, which allows us
placebo.
836
ª 2014 VDF FutureCeuticals, Inc. Food Science & Nutrition published by Wiley Periodicals, Inc.
B. V. Nemzer et al.
New Insights on Effects of a Dietary Supplement
Conclusions
Broedbaek, K., V. Siersma, T. Henriksen, A. Weimann, M.
Petersen, J. Andersen, et al. 2013. Association between
For the first time, we were able to measure the biological
urinary markers of nucleic acid oxidation and mortality in
effects of a natural dietary supplement on changes of
type 2 diabetes: a population-based cohort study. Diabetes
oxidative and nitrosative stress markers and cellular
Care 36:669676.
metabolic activity through the use of the extended Vital-
Chen, J., R. Hu, and H. Chou. 2013. Quercetin-induced
ity Test. Unique activity of SPECTRATM suggests poten-
cardioprotection against doxorubicin cytotoxicity. J.
tial for the use of the supplement in modulation of
Biomed. Sci. 20:95.
oxidative stress, NO bioavailability, inflammatory
Chung, H., H. Choi, J. Park, J. Choi, and W. Choi. 2001.
response, blood glucose levels, and ultimately supporting
Peroxynitrite scavenging and cytoprotective activity of
optimal health.
2,3,6-tribromo-4,5-dihydroxybenzyl methyl ether from the
marine alga Symphyocladia latiuscula. J. Agric. Food Chem.
49:36143621.
Acknowledgments
Dikalov, S., and B. Fink. 2005. ESR techniques for the
Herewith we thank Dr. V. Kagan (Director of the Center
detection of nitric oxide in vivo and in tissues. Methods
for Free Radical and Antioxidant Health, Vice-Chairman
Enzymol. 396:597610.
of the Environmental and Occupational Health Depart-
Dikalov, S., M. Skatchkov, B. Fink, O. Sommer, and E.
ment at the University of Pittsburgh) and Dr. A. M. Za-
Bassenge. 1998. Formation of reactive oxygen species in
fari (Associate Professor of Medicine and Director of the
various vascular cells during glyceryltrinate metabolism.
Cardiovascular Training Program at Emory University
J. Cardiovasc. Pharmacol. Ther. 3:5162.
School of Medicine), John M. Hunter, and Brad Evers
Dikalov, S., K. K. Griendling, and D. G. Harrison. 2007.
(FutureCeuticals, Inc.) for review and helpful discussion
Measurement of reactive oxygen species in cardiovascular
during editing of this manuscript. The authors also thank
studies. Hypertension 49:717727.
Dr. Luis Valera for his independent statistical analysis of
Dikalov, S., I. Kirilyuk, M. Voinov. and I. A. Grigorev. 2011.
EPR detection of cellular and mitochondrial superoxide
data reported in this article.
using cyclic hydroxylamines. Free Radic. Res. 45:417430.
Dikalov, S., W. Li, A. Doughan, R. Blanco, and A. Zafari. 2012.
Conflict of Interest
Mitochondrial reactive oxygen species and calcium uptake
regulate activation of phagocytic NADPH oxidase. Am. J.
None declared.
Physiol. Regul. Integr. Comp. Physiol. 302:R1134R1142.
Dikalova, A., A. Bikineyeva, K. Budzyn, R. Nazarewicz, L.
References
McCann, W. Lewis, et al. 2010. Therapeutic targeting of
Annapurna, A., C. Reddy, R. Akondi, and S. Rao. 2009.
mitochondrial superoxide in hypertension. Circ. Res.
Cardio-protective actions of two bioflavonoids, Quercetin
107:106116.
and rutin, in experimental myocardial infarctionin both
Droge,€ W. 2002. Free radicals in the physiological control of
normal and streptozotocin-induced type I diabetic rats.
cell function. Physiol. Rev. 82:4795.
J. Pharm. Pharmacol. 61:13651374.
Feuerstein, G., T. Liu, and F. Barone. 1994. Cytokines,
Bailey, E., M. McBride, W. Crawford, J. McClure, D.
inflammation, and brain injury: role of tumor necrosis
Graham, A. Dominiczak, et al. 2014. Differential gene
factor-alpha. Cerebrovasc. Brain Metab. Rev. 6:341360.
expression in multiple neurological, inflammatory and
Fink, B., S. Dikalov, and E. Bassenge. 2000. A new approach
connective tissue pathways in a spontaneous model of
for extracellular spin trapping of nitroglycerin-induced
human small vessel stroke. Neuropathol. Appl. Neurobiol.
superoxide radicals both in vitro and in vivo. Free Radic.
doi: 10.1111/nan.12116. [Epub ahead of print].
Biol. Med. 28:121128.
Bassenge, E., N. Fink, M. Skatchkov, and B. Fink. 1998.
Harman, D. 1956. AgingA theory based on free-radical and
Dietary supplement with vitamin C prevents nitrate
radiation-chemistry. J. Gerontol. 11:298300.
tolerance. J. Clin. Invest. 102:6771.
Huang, D., B. Ou, J. Hampsch-Woodill, J. Flanagan, and R.
Bobko, A., I. Dhimitruka, T. Eubank, C. Marsh, J. Zweier, and
Prior. 2002. High-throughput assay of oxygen radical
V. Khramtsov. 2009. Trityl-based EPR probe with enhanced
absorbance capacity (ORAC) using a multichannel liquid
sensitivity to oxygen. Free Radic. Biol. Med. 47:654658.
handling system coupled with a microplate
Boesch-Saadatmandi, C., A. Lobada, A. Wagner, A. Stachurska,
fluorescencereader in 96-well format. J. Agric. Food Chem.
A. Jorkowicz, J. Dulak, et al. 2011. Effect of quercetin and
50:44374444.
its metabolites isorhamnetin and quercetin-3-glucuronide on
Imai, K., and K. Nakachi. 1995. Cross sectional study of effects
inflammatory gene expression: role of miR-155. J. Nutr.
of drinking green tea on cardiovascular and liver diseases.
Biochem. 22:293299.
BMJ 310:693696.
ª 2014 VDF FutureCeuticals, Inc. Food Science & Nutrition published by Wiley Periodicals, Inc.
837
New Insights on Effects of a Dietary Supplement
B. V. Nemzer et al.
Ji, J., A. E. Kline, A. Amoscato, A. S. Arias, L. J. Sparvero, V.
Mullen, W., B. Nemzer, B. Ou, J. Stalmach, J. Hunter, and M.
A. Tyurin, et al. 2012. Global lipidomics identifies
Clifford. 2011. The antioxidant and chlorogenic acid
cardiolipin oxidation as a mitochondrial target for redox
profilesof whole coffee fruits and influenced by the
therapy of acute brain injury. Nat. Neurosci. 15:14071413.
extraction procedures. J. Agric. Food Chem. 59:37543762.
Jung, U., M. Lee, Y. Park, S. Jeon, and M. Choi. 2006.
Nakachi, K., S. Matsuyama, S. Miyake, M. Suganuma, and K.
Antihyperglycemic and antioxidant properties of caffeic acid
Imai. 2000. Preventive effects of drinking green tea on
in db/db mice. J. Pharmacol. Exp. Ther. 318:476483.
cancer and cardiovascular disease: epidemiological evidence
Komarov, D., I. Dhimitruka, I. Kirilyuk, D. Trofimiov, I.
for multiple targeting prevention. BioFactors 13:4954.
Grigorev, J. Zweier, et al. 2012. Electron paramagnetic
Nazarewicz, R., A. Dikalova, A. Bikineyeva, S. Ivanov, I.
resonance monitoring of ischemia-induced myocardial
Kirilyuk, I. Grigorev, et al. 2013. Does scavenging of
oxygen depletion and acidosis in isolated rat hearts using
mitochondrial superoxide attenuate cancer prosurvival
soluble paramagnetic probes. Magn. Reson. Med. 68:649
signaling pathways? Antioxid. Redox Signal. 19:344349.
655.
Nemzer, B., T. Chang, Z. Xie, Z. Pietrzkowski, T. Reyes, and
Kovacic, P., and J. Jacintho. 2001. Mechanisms of
B. Ou. 2014. Decrease of free radical concentrations in
carcinogenesis: focus on oxidative stress and electron
humans following consumption of a high antioxidant
transfer. Curr. Med. Chem. 8:773796.
capacity natural product. Food Sci. Nutr. 2:18.
Kuriyama, S. 2008. The relation between green tea
Ohga, N., K. Hida, Y. Hida, C. Muraki, K. Tsuchiya, K.
consumption and cardiovascular disease as evidenced by
Matsuda, et al. 2009. Inhibitory effects of epigallocatechin-3
epidemiological studies. J. Nutr. 138:1548S1553S.
gallate, a polyphenol in green tea, on tumor-associated
Kuriyama, S., T. Shimazu, K. Ohmori, N. Kikuchi, N.
endothelial cells and endothelial progenitor cells. Cancer Sci.
Nakaya, Y. Nishino, et al. 2006. Green tea consumption
100:19631970.
and mortality due to cardiovascular disease, cancer, and
Ou, B., J. Hampsch-Woodill, E. Flanagan, E. Deemer, R. Prior,
All causes in Japan: the Ohsaki study. JAMA 296:1255
and D. Hung. 2002. Novel fluorometric assay for hydroxyl
1265.
radical prevention capacity using fluorescein as the probe.
Lang, A., M. Lahav, E. Sakhnini, I. Barshack, H. Fidder, B.
J. Agric. Food Chem. 50:27722777.
Avidan, et al. 2004. Allicin inhibits spontaneous and
Pisaneschi, S., F. Strigini, A. Sanchez, S. Begliuomini, E.
TNF-alpha induced secretion of proinflammatory cytokines
Casarosa, A. Ripoli, et al. 2012. Compensatory feto-placental
and chemokines from intestinal epithelial cells. Clin. Nutr.
upregulation of the nitric oxide system during fetal growth
23:11991208.
restriction. PLoS One 7:e452e494.
Mah, E., S. Noh, K. Ballard, H. Park, J. Volek, and R. Bruno.
Ridnour, L., J. Isenberg, M. Espey, D. Thomas, D. Roberts,
2013. Supplementation of a c-tocopherol-rich mixture of
and D. Wink. 2005. Nitric oxide regulates angiogenesis
tocopherols in healthy men protects against vascular
through a functional switch involving thrombospondin-1.
endothelial dysfunction induced by postprandial
Proc. Natl. Acad. Sci. USA 102:1314713152.
hyperglycemia. J. Nutr. Biochem. 21:196203.
Rustan, A., B. Halvorsen, T. Ranheim, and C. Dreven. 1997.
Manach, C., G. Williamson , C. Morand, A. Scalbert, and C.
Cafestol (a coffee lipid) decreases uptake of low-density
R*em*esy. 2005. Bioavailability and bioefficacy of polyphenols
lipoprotein in human skin fibroblasts and liver cells. Ann.
in humans. I. Review of 97 bioavailability studies. Am. J.
N. Y. Acad. Sci. 827:158162.
Clin. Nutr., 81(1 Suppl.): 230S242S.
Sano, J., S. Inami, K. Seimiya, T. Ohba, S. Sakai, T. Takano,
Mariappan, N., C. Elks, B. Fink, and J. Frncis. 2009.
et al. 2004. Effects of green tea intake on the development
TNF-induced mitochondrial damage: a link between
of coronary artery disease. Circ. J. 68:665670.
mitochondrial complex I activity and left ventricular
Sasazuki, S., H. Kodama, K. Yoshimasu, Y. Liu, M. Washio, K.
dysfunction. Free Radic. Biol. Med. 46:462470.
Tanaka, et al. 2000. Relation between green tea
McCord, J., and I. Fridovich. 1969. Superoxide dismutase an
consumption and the severity of coronary atherosclerosis
enzyme function for erythrocuprein Hemocuprein. J. Biol.
among japanese men and women. Ann. Epidemiol. 10:401
Chem. 244:60496055.
408.
Miron, T., A. Rabinkov, D. Milerman, M. Wilchek, and L.
Seo, K., J. Yang, S. Kim, S. Ku, S. Ki, and S. Shin. 2013. The
Weiner. 2000. The mode of action of allicin: its ready
antioxidant effects of isorhamnetin contribute to inhibit
permeability through phospholipid membranes may
COX-2 expression in response to inflammation: a potential
contribute to its biological activity. Biochim. Biophys.
role of HO-1. Inflammation 37:712722.
1463:2030.
Sesso, H. D., J. M. Gaziano, J. E. Buring, and C. H.
Mrakic-Sposta, S., M. Gussoni, M. Montorsi, S. Porcelli, and
Hennekens. 1999. Coffee and tea intake and the risk of
A. Vezzoli. 2012. Assessment of a standardized ROS
myocardial infarction. Am. J. Epidemiol. 149:162167.
production profile in humans by electron paramagnetic
Sohal, R., and W. Orr. 2012. The redox stress hypothesis of
resonance. Oxid. Med. Cell. Longev. 5:973927.
aging. Free Radic. Biol. Med. 52:539555.
838
ª 2014 VDF FutureCeuticals, Inc. Food Science & Nutrition published by Wiley Periodicals, Inc.
B. V. Nemzer et al.
New Insights on Effects of a Dietary Supplement
Suvorava, T., N. Lauer, S. Kumpf, R. Jacob, W. Meyer, and G.
NADPH oxidase is associated with reduced respiratory burst
Kojda. 2005. Endogenous vascular hydrogen peroxide
in human neutrophils. Hypertension 43:12461251.
regulates arteriolar tension in vivo. Circulation 112:2487
Yamamoto, Y., K. Matsunaga, and H. Friedman. 2004.
2495.
Protective effects of green tea catechins on alveolar
Valko, M., H. Morris, M. Mazur, P. Rapta, and R. Bilton.
macrophages against bacterial infections. BioFactors 21:119
2001. Oxygen free radical generating mechanisms in the
121.
colon: do the semiquinones of Vitamin K play a role in the
Yan, H., K. Peng, Q. Wang, Z. Gu, Y. Lu, J. Zhao, et al. 2013.
aertiology of colon cancer? Biochim. Biophys. Acta
Effect of pomegranate peel polyphenol gel on cutaneous
1527:161166.
wound healing in alloxan-induced diabetic rats. Chin. Med.
Wadsworth, T., and D. Koop. 2001. Effects of Ginkgo biloba
J. (Engl.) 126:17001706.
extract (EGb 761) and Quercetin on
Zhang, L., D. Huang, M. Kondo, E. Fan, and B. Ou. 2009.
lipopolysaccharide-induced release of nitric oxide. Chem.
Novel high-throughput assay for antioxidant capacity
Biol. Interact. 137:4358.
against superoxide anion. J. Agric. Food Chem. 57:2661
Wadsworth, T., T. Msdonald, and D. Koop. 2001. Effects of
2667.
Ginkgo biloba extract (EGb 761) and Quercetin on
Zhao, H., S. Kalivendi, H. Zhang, J. Joseph, K. Nithipatikom,
lipopolysaccharide-induced signaling pathways involved in
J. Vasquez-Vivar, et al. 2003. Superoxide reacts with
the release of tumor necrosis factor-alpha. Biochem.
hyrdoethidine but forms a fluorescent product that is
Pharmacol. 62:963974.
distinctly different from ethidium: potential implications in
Watanabe, T., Y. Arai, Y. Mitsuri, T. Kusaura, W. Okawa, and
intracellular fluorescence detection of superoxide. Free
Y. Kajihara. 2006. The blood pressure-lowering effect and
Radic. Biol. Med. 34:13591368.
safety of chlorogenic acid from green coffee bean extract in
Zielonka, J., H. Zhao, Y. Xu, and B. Kalyanaraman. 2005.
essential hypertension. Clin. Exp. Hypertens. 28:439449.
Mechanistic similarities between oxidation of hydroethidine
Wyche, K., S. Wang, K. Griendling, S. Dikalov, H. Austin, S.
by Fremys salt and superoxide: stopped-flow optical and
Rao, et al. 2004. C242T CYBA polymorphism of the
EPR studies. Free Radic. Biol. Med. 39:853863.
ª 2014 VDF FutureCeuticals, Inc. Food Science & Nutrition published by Wiley Periodicals, Inc.
839
Brief summary of proof-‐of-‐concept clinical trial to evaluate the efficacy of HydroMax™ adjunct to a
carbohydrate-‐electrolyte solution in healthy subjects with dehydration/thermoregulatory stress during
exercise
Objective: To assess the effects of HydroMax™ on biomarkers of hydration status, total body water and
intracellular fluid status, and subjective ratings of exertion when added to a standard CHO/Electrolyte
solution under exercise conditions of dehydration/ thermoregulatory stress.
Study Design:
•
Randomi zed, single-‐blinded, crossover trial in healthy, recreationally active adults: N=3 (1 female/ 2 males);
three total visits to lab ([1] screen/baseline assessment; [2] Trial A/B; [3] Trial B/A)
•
(A) 12 fl. oz (354 mL) of carbohydrate-electrolyte solution vs. (B) 12 fl. oz carbohydrate-electrolyte solution + 2g
HydroMax™ consumed prior to 60min bicycle ergometer
exercise stress test
•
Baseline measurements, before and after the 60 min cycle ergometer for various biomark ers of hydration/fluid
balance status
•
60min exercise bout on cycle ergometer at HR equiv to 65% VO2 max; RPE measured at the 30min (mid-‐point
of exercise bout) and 60min mark (during last minute of exercise bout)
Primary Objective:
•
Dependent Variables at Visits 2 and 3: Nude Bodyweight; Usg, Uosm, Ucr, Usodium, Plasma Hgb/Hct,
Plasma Osm, Plasma Cr, Plasma sodium (Chem panel + Hgb/Hct + Plasma Osm); BIA for TBW, ICF & ECF; RPE
(pre, 30min into exercise stress, immediately post-‐exercise)
Comments on Preliminary Pilot Data:
•
In general, notable findings for the carbohydrate-electrolyte solution + HydroMax™ trial were: 1) less
decrease in nude body weight; 2) less loss of total body water (TBW, in fact it increased slightly during
the trial); lower rating of perceived exertion (RPE); and 4) less of a decrease in plasma volume (as measured
by changes in hematocrit, HCT).
•
Given the use of a well-‐established, effective carbohydrate/electrolyte rehydration solution as the
comparator, these subtle, yet consistent differences demonstrating the potential superiority of the
carbohydrate-electrolyte solution + low dose HydroMax™ appear very promising.
•
These preliminary data suggests (within the confines and limitations of this small pilot) there is credence
to the hypothesis that HydroMax is providing additive hydration, thermoregulatory support beyond a
leading 6% carb/electrolyte solution under exercise conditions with exercise stress in healthy adults.
2
Table 1: Data represent the average % change from baseline (pre-‐exercise) during the Carbohydrate-Electrolyte
Solution trial vs. the Carbohydrate-Electrolyte Solution plus HydroMax™ trial. Each subject served as their own
control.
2
September 2017
Page 1/13
Key references related to the physiological benefits of Palatinose™
PalatinoseTM – a carbohydrate with unique physiological properties
Palatinose™ (generic name: isomaltulose) is a disaccharide carbohydrate derived from sucrose by enzymatic
rearrangement of the linkage. The different linkage turns Palatinose™ into a “slow release carbohydrate” with a
unique combination of physiological properties: As result of its slow yet complete digestion and absorption,
Palatinose™ has a low effect on blood glucose levels (GI: 32) and insulin release. It provides carbohydrate energy in
a more balanced way over a longer period of time. And thus it contributes to modern energy management with
characteristics like steadier energy supply and a higher contribution of fat oxidation. Apart from that, Palatinose™ is
kind to teeth. The slow release properties, the higher fat oxidation and tooth-friendliness are all unique to
Palatinose™ and make it different from sugars like fructose or sucrose and HFCS or from malto-oligosaccharides.
BENEO has undertaken comprehensive research to study the unique nutritional and physiological properties of this
functional carbohydrate. Some of these studies have not been published yet for reasons of the still unclear
situation in the handling of proprietary data under the European Health Claim Regulation. An overview of the most
relevant publications on the physiological properties of Palatinose™ is given in the following, while more detailed
information can be shared under confidentiality agreement:
Table of Content:
1. Palatinose™ - a fully available carbohydrate for slow and sustained energy release ............................... 2
a) PalatinoseTM is a fully available carbohydrate............................................................................. 2
b) PalatinoseTM is a slow and sustained release carbohydrate........................................................ 2
c) Palatinose™ - the carbohydrate for sustained energy supply..................................................... 3
2. Palatinose™ - a low glycemic carbohydrate .............................................................................................. 4
3. Palatinose™ and long-term blood glucose control and insulin sensitivity ................................................ 6
4. Palatinose™ and its role in weight management ...................................................................................... 7
a) Palatinose™ and its influence on fat oxidation in energy metabolism ....................................... 7
b) Long-term benefits of Palatinose™ on body weight and body composition .............................. 9
5. Palatinose™ in sports nutrition ............................................................................................................... 10
6. Palatinose™ and its potential in cognitive performance and mood........................................................ 11
7. Palatinose™ is kind to teeth .................................................................................................................... 12
8. Palatinose™ in infant and small children nutrition.................................................................................. 12
September 2017
Page 2/13
1. Palatinose™ - a fully available carbohydrate for slow and sustained energy release
a) PalatinoseTM is a fully available carbohydrate
The essentially complete digestion and absorption of Palatinose™ within the small intestine has been confirmed in
human and animal studies. Palatinose™ is a fully digestible carbohydrate and as such provides the full carbohydrate
energy (4 kcal/g), respectively.
Key references:
Holub I, Gostner A, Theis S, Nosek L, Kudlich T, Melcher R, Scheppach W (2010) Novel findings on the metabolic
effects of the low glycaemic carbohydrate isomaltulose (Palatinose™). Br J Nutr 103(12):1730–1737. (see trial 1 for
ileostomy study) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2943747/pdf Accessed September 4, 2017.
Tonouchi H, Yamaji T, Uchida M, Koganei M, Sasayama A, Kaneko T, Urita Y, Okuno M, Suzuki K, Kashimura J, Sasaki
H (2011) Studies on absorption and metabolism of palatinose (isomaltulose) in rats. Br J Nutr 105(1):10–14.
http://www.ncbi.nlm.nih.gov/pubmed/20807468 Accessed September 4, 2017.
b) PalatinoseTM is a slow and sustained release carbohydrate
The “slow release” aspect is based on enzyme kinetic studies which show that the enzymatic hydrolysis of
Palatinose™ in the small intestine occurs much slower than that of e.g. sucrose (i.e. difference in Vmax by a factor of
4-5). Observations on incretin hormones illustrate that the digestion of Palatinose™ and subsequent absorption is a
slow process that is extended to more distal parts of the small intestine.
References:
Enzyme kinetics
Dahlqvist A (1961) Hydrolysis of palatinose (Isomaltulose) by pig intestinal glycosidases. Acta Chem Scand
15(4):808–816. http://actachemscand.org/pdf/acta_vol_15_p0808-0816.pdf Accessed September 4, 2017.
Grupp U, Siebert G (1978) Metabolism of hydrogenated palatinose, an equimolar mixture of alpha-D-
glucopyranosido-1,6-sorbitol and alpha-D-glucopyranosido-1,6-mannitol. Res Exp Med (Berlin) 173(3):261–278.
http://www.ncbi.nlm.nih.gov/pubmed/364572 Accessed September 4, 2017.
Heinz F (1987) The enzymatic splitting of sugar substitutes by isolated enzymes and enzyme complexes from the
small intestinal mucosa. Hanover University Medical School, Biochemistry Centre, Research Project No. 6539.
Tsuji Y (1986) Digestion and absorption of sugars and sugar substitutes in rat small intestine. J Nutr Sci Vitaminol
32:93–100. http://www.ncbi.nlm.nih.gov/pubmed/3712112 Accessed September 4, 2017.
September 2017
Page 3/13
Yamada K, Shinohara H, Hosoya N (1985) Hydrolysis of 1-O-α-D-glucopyranosyl-D-fructofuranose (trehalulose) by
rat intestinal sucrase-isomaltase complex. Nutr Rep Int 32(5):1221-1220.
Ziesenitz SC (1986a) Zur Verwertung des Zuckeraustauschstoffes Palatinit im Stoffwechsel. [Utilization of the sugar
substitute Palatinit® in metabolism]. In: Bässler K, Grünert A, Kleinberger G, Reissigl H (eds) Beiträge zu
Infusionstherapie und klinische Ernährung 16. Karger, Basel, pp 120–132.
Ziesenitz SC (1986b) Stufenweises Prüfschema für Zuckeraustauschstoffe - Vorprüfung mittels Enzymen. 3.
Carbohydrasen aus Jejunalmucosa des Menschen. [A stepwise method of evaluating sugar substitutes - a
preliminary study using enzymes. 3. Carbohydrases from the human jejunal mucosa]. Z Ernahrungswiss 25:253–
258. http://link.springer.com/article/10.1007/BF02019577 Accessed September 4, 2017.
Incretins
Maeda A, Miyagawa J, Miuchi M, Nagai E, Konishi K, Matsuo T, Tokuda M, Kusunoki Y, Ochi H, Murai K, Katsuno T,
Hamaguchi T, Harano Y, Namba M (2013) Effects of the naturally-occurring disaccharides, palatinose and sucrose,
on incretin secretion in healthy non-obese subjects. J Diabetes Investig. 4(3):281–286.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015665/pdf Accessed September 4, 2017.
Ang M, Linn T (2014) Comparison of the effects of slowly and rapidly absorbed carbohydrates on postprandial
glucose metabolism in type 2 diabetes mellitus patients: a randomized trial. Am J Clin Nutr 100(4):1059–1068.
http://ajcn.nutrition.org/content/early/2014/07/16/ajcn.113.076638.full.pdf Accessed September 4, 2017.
Keyhani-Nejad F, Kemper M, Schueler R, Pivovarova O, Rudovich N, Pfeiffer AF (2016) Effects of Palatinose and
Sucrose Intake on Glucose Metabolism and Incretin Secretion in Subjects With Type 2 Diabetes. Dia Care 39(3):e38-
e39. http://care.diabetesjournals.org/content/39/3/e38.full-text.pdf Accessed September 4, 2017.
c) Palatinose™ - the carbohydrate for sustained energy supply
The sustained energy supply of Palatinose™ is a result of its slow yet complete digestion and absorption along the
small intestine and is reflected in subsequent metabolic processes: In comparison with readily available
carbohydrates, Palatinose™ shows a slower, overall lower and sustained rise in blood glucose levels. Since blood
glucose means fuel for the body and its energy metabolism, the sustained glucose supply from Palatinose™ is
associated with a more steady and sustained energy gain from carbohydrate oxidation: Palatinose™ provides
sustained energy.
Numerous blood glucose response studies have been conducted on behalf of BENEO and specifically analyzed to
test whether the characteristics of sustained glucose supply from Palatinose™ can be shown in this methodology
with its high variance. The sustained glucose supply of Palatinose™ has been concomitantly shown in all of these
studies. Moreover, individual studies confirm the link between sustained glucose supply and sustained
carbohydrate oxidation.
September 2017
Page 4/13
2. Palatinose™ - a low glycemic carbohydrate
As result of its slow (yet complete) intestinal release, Palatinose™ has a low effect on blood glucose levels and
insulin release. A Glycemic Index (GI) of 32 has been determined for Palatinose™ by Sydney University.
The “low glycemic” properties of Palatinose™ have been experimentally verified in extensive research initiated by
BENEO - including more than 30 human trials from the past 5 to 10 years conducted according to internationally
recognized standard methodology in leading test centers worldwide (see Figure on the right) - and are well
described in literature. A corresponding claim has been laid down in EU legislation following the publication of a
positive EFSA opinion.
References of published blood glucose response studies:
Sydney University’s Glycaemic Research Service (SUGiRS) (2002): See GI Database at www.glycemicindex.com
Accessed September 4, 2017.
Ang M, Linn T (2014) Comparison of the effects of slowly and rapidly absorbed carbohydrates on postprandial
glucose metabolism in type 2 diabetes mellitus patients: a randomized trial. Am J Clin Nutr 100(4):1059–1068.
http://ajcn.nutrition.org/content/early/2014/07/16/ajcn.113.076638.full.pdf Accessed September 4, 2017.
Henry CJ, Kaur B, Quek RYC, Camps SG (2017) A Low Glycaemic Index Diet Incorporating Isomaltulose Is Associated
with Lower Glycaemic Response and Variability, and Promotes Fat Oxidation in Asians. Nutrients 9(5).
http://www.mdpi.com/2072-6643/9/5/473/htm Accessed September 4, 2017.
September 2017
Page 5/13
Holub I, Gostner A, Theis S, Nosek L, Kudlich T, Melcher R, Scheppach W (2010) Novel findings on the metabolic
effects of the low glycaemic carbohydrate isomaltulose (Palatinose™). Br J Nutr 103(12):1730–1737. (see trial 1 for
ileostomy study) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2943747/pdf Accessed September 4, 2017.
Kahlhöfer J, Karschin J, Silberhorn-Bühler H, Breusing N, Bosy-Westphal A, Kahlhofer J, Silberhorn-Buhler H (2016)
Effect of low glycemic-sugar-sweetened beverages on glucose metabolism and macronutrient oxidation in healthy
men. Int J Obes (Lond) 40(6):990–997. https://www.ncbi.nlm.nih.gov/pubmed/26869244 Accessed September 4,
2017.
Kawai K, Okuda Y, Yamashita K (1985) Changes in blood glucose and insulin after an oral palatinose administration
in normal subjects. Endocrinol Jpn 32:933–936.
https://www.jstage.jst.go.jp/article/endocrj1954/32/6/32_6_933/_pdf Accessed September 4, 2017.
Kawai K, Yoshikawa H, Murayama Y, Okuda Y, Yamashita K (1989) Usefulness of palatinose as a caloric sweetener
for diabetic patients. Horm Metab Res 21(6):338–340. http://www.ncbi.nlm.nih.gov/pubmed/2673967 Accessed
September 4, 2017.
Keyhani-Nejad F, Kemper M, Schueler R, Pivovarova O, Rudovich N, Pfeiffer AF (2016) Effects of Palatinose and
Sucrose Intake on Glucose Metabolism and Incretin Secretion in Subjects With Type 2 Diabetes. Dia Care 39(3):e38-
e39. http://care.diabetesjournals.org/content/39/3/e38.full-text.pdf Accessed September 4, 2017.
König D, Theis S, Kozianowski G, Berg A (2012) Postprandial substrate use in overweight subjects with the metabolic
syndrome after isomaltulose (Palatinose™) ingestion. Nutrition 28(6):651–656.
http://www.nutritionjrnl.com/article/S0899-9007(11)00361-3/pdf Accessed September 4, 2017.
Liao Z, Li Y, Yao B, Fan H, Hu GL, Weng J (2001) The effects of isomaltulose on blood glucose and lipids for diabetic
subjects. Diabetes 50(Supplement):1530-P, A366.
Macdonald I, Daniel JW (1983) The bio-availability of isomaltulose in man and rat. Nutr Rep Int 28:1083–1090.
http://openagricola.nal.usda.gov/Record/FNI84005129 Accessed September 4, 2017.
Maeda A, Miyagawa J, Miuchi M, Nagai E, Konishi K, Matsuo T, Tokuda M, Kusunoki Y, Ochi H, Murai K, Katsuno T,
Hamaguchi T, Harano Y, Namba M (2013) Effects of the naturally-occurring disaccharides, palatinose and sucrose,
on incretin secretion in healthy non-obese subjects. J Diabetes Investig. 4(3):281–286.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015665/pdf Accessed September 4, 2017.
Sridonpai P (2016) Impact of Isomaltulose and Sucrose based breakfasts on postprandial substrate oxidation and
glycemic/insulinemic changes in type-2 diabetes mellitus subjects. J Med Assoc Thai 99(3):282–289.
http://www.jmatonline.com/index.php/jmat/article/view/6980 Accessed September 4, 2017.
September 2017
Page 6/13
van Can, Judith G P, Ijzerman TH, van Loon, Luc J C, Brouns F, Blaak EE (2009) Reduced glycaemic and insulinaemic
responses following isomaltulose ingestion: implications for postprandial substrate use. Br J Nutr 102(10):1408–
1413. http://www.ncbi.nlm.nih.gov/pubmed/19671200 Accessed September 4, 2017.
Yamori Y, Mori H, Mori M, Kashimura J, Sakamua T, Ishikawa PM, Moriguchi E, Moriguchi Y (2007) Japanese
perspective on reduction in lifestyle disease risk in immigrant japanese brazilians: a double-blind, placebo-
controlled intervention study on palatinose. Clin Exp Pharmacol Physiol 34(S5-S7).
http://onlinelibrary.wiley.com/doi/10.1111/j.1440-1681.2007.04759.x/epdf Accessed September 4, 2017.
Reviews:
EFSA Panel on Dietetic Products, Nutrition and Allergies (2011) Scientific Opinion on the substantiation of health
claims related to the sugar replacers xylitol, sorbitol, mannitol, lactitol, isomalt, erythritol, D-tagatose, isomaltulose,
sucralose and polydextrose and maintenance of tooth mineralization by decreasing tooth demineralization (…), and
reduction of post-prandial glycemic responses (…) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA
Journal 9(4):2076. http://www.efsa.europa.eu/de/efsajournal/doc/2076.pdf Accessed September 4, 2017.
Maresch CC, Petry SF, Theis S, Bosy-Westphal A, Linn T (2017) Low Glycemic Index Prototype Isomaltulose-Update
of Clinical Trials. Nutrients 9(4). http://www.mdpi.com/2072-6643/9/4/381 Accessed September 4, 2017.
3. Palatinose™ and long-term blood glucose control and insulin sensitivity
Longer-term studies investigated the effects of PalatinoseTM on markers of blood glucose control and insulin
sensitivity such as glycated haemoglobin HbA1c, fructosamine, effects on long-term postprandial glucose and
insulin response curves, fasting glucose and insulin (HOMA).
These include following references:
Holub I, Gostner A, Theis S, Nosek L, Kudlich T, Melcher R, Scheppach W (2010) Novel findings on the metabolic
effects of the low glycaemic carbohydrate isomaltulose (Palatinose™). Br J Nutr 103(12):1730–1737.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2943747/pdf Accessed September 4, 2017.
Keller J, Kahlhöfer J, Peter A, Bosy-Westphal A (2016) Effects of Low versus High Glycemic Index Sugar-Sweetened
Beverages on Postprandial Vasodilatation and Inactivity-Induced Impairment of Glucose Metabolism in Healthy
Men. Nutrients 8(12):802. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5188457/pdf Accessed September 4,
2017.
Okuno M, Kim MK, Mizu M, Mori M, Mori H, Yamori Y (2010) Palatinose-blended sugar compared with sucrose:
different effects on insulin sensitivity after 12 weeks supplementation in sedentary adults. Int J Food Sci Nutr
61(6):643–651. http://www.ncbi.nlm.nih.gov/pubmed/20367218 Accessed September 4, 2017.
September 2017
Page 7/13
Oizumi T, Daimon M, Jimbu Y, Kameda W, Arawaka N, Yamaguchi H, Ohnuma H, Sasaki H, Kato T (2007) A
palatinose-based balanced formula improves glucose tolerance, serum free fatty acid levels and body fat
composition. Tohoku J Exp Med 212(2):91–99. https://www.jstage.jst.go.jp/article/tjem/212/2/212_2_91/_pdf
Accessed September 4, 2017.
Sakuma M, Arai H, Mizuno A, Fukaya M, Matsuura M, Sasaki H, Yamanaka-Okumura H, Yamamoto H, Taketani Y,
Doi T, Takeda E (2009) Improvement of glucose metabolism in patients with impaired glucose tolerance or diabetes
by long-term administration of a palatinose-based liquid formula as a part of breakfast. J Clin Biochem Nutr
45(2):155–162. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2735627/pdf Accessed September 4, 2017.
Brunner S, Holub I, Theis S, Gostner A, Melcher R, Wolf P, Amann-Gassner U, Scheppach W, Hauner H (2012)
Metabolic Effects of Replacing Sucrose by Isomaltulose in Subjects With Type 2 Diabetes: A randomized double-
blind trial. Diabetes Care 35(6):1249–1251. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3357231/pdf Accessed
September 4, 2017.
4. Palatinose™ and its role in weight management
As result of its slow release properties and resulting lower and sustained blood glucose response, Palatinose™
triggers less insulin release and therefore enables higher fat oxidation in energy metabolism. Higher levels of fat
burning with Palatinose™ in comparison with conventional carbohydrates such as e.g. sucrose or maltodextrin (but
also in comparison with fructose) have been observed in human intervention studies with healthy and overweight
individuals at mostly sedentary conditions (see below) as well as with physically active trained persons (see 5.).
Related long-term benefits of Palatinose™ refer to body weight and body composition: Longer-term feeding studies
in animals reported beneficial effects of PalatinoseTM on body fat accumulation and body weight. Some publications
provide first human data on the effect of PalatinoseTM on body composition, i.e. visceral fat accumulation.
New research on the effects of PalatinoseTM on body weight and body composition has not been published yet.
a) Palatinose™ and its influence on fat oxidation in energy metabolism
König D, Theis S, Kozianowski G, Berg A (2012) Postprandial substrate use in overweight subjects with the metabolic
syndrome after isomaltulose (Palatinose™) ingestion. Nutrition 28(6):651–656.
http://www.nutritionjrnl.com/article/S0899-9007(11)00361-3/pdf Accessed September 4, 2017.
Arai H, Mizuno A, Sakuma M, Fukaya M, Matsuo K, Muto K, Sasaki H, Matsuura M, Okumura H, Yamamoto H,
Taketani Y, Doi T, Takeda E (2007) Effects of a palatinose-based liquid diet (Inslow) on glycemic control and the
second-meal effect in healthy men. Metabolism 56(1):115–121. (Note: this study also shows a second meal effect).
http://www.ncbi.nlm.nih.gov/pubmed/17161233 Accessed September 4, 2017.
Henry CJ, Kaur B, Quek RYC, Camps SG (2017) A Low Glycaemic Index Diet Incorporating Isomaltulose Is Associated
with Lower Glycaemic Response and Variability, and Promotes Fat Oxidation in Asians. Nutrients 9(5).
http://www.mdpi.com/2072-6643/9/5/473/htm Accessed September 4, 2017.
September 2017
Page 8/13
Kahlhöfer J, Karschin J, Silberhorn-Bühler H, Breusing N, Bosy-Westphal A, Kahlhofer J, Silberhorn-Buhler H (2016)
Effect of low glycemic-sugar-sweetened beverages on glucose metabolism and macronutrient oxidation in healthy
men. Int J Obes (Lond) 40(6):990–997. https://www.ncbi.nlm.nih.gov/pubmed/26869244 Accessed September 4,
2017.
Sridonpai P (2016) Impact of Isomaltulose and Sucrose based breakfasts on postprandial substrate oxidation and
glycemic/insulinemic changes in type-2 diabetes mellitus subjects. J Med Assoc Thai 99(3):282–289.
http://www.jmatonline.com/index.php/jmat/article/view/6980 Accessed September 4, 2017.
van Can, Judith G P, Ijzerman TH, van Loon, Luc J C, Brouns F, Blaak EE (2009) Reduced glycaemic and insulinaemic
responses following isomaltulose ingestion: implications for postprandial substrate use. Br J Nutr 102(10):1408–
1413. http://www.ncbi.nlm.nih.gov/pubmed/19671200 Accessed September 4, 2017.
September 2017
Page 9/13
van Can JG, van Loon LJ, Brouns F, Blaak EE (2012) Reduced glycaemic and insulinaemic responses following
trehalose and isomaltulose ingestion: implications for postprandial substrate use in impaired glucose-tolerant
subjects. Br J Nutr 108(7):1210–1217. http://www.ncbi.nlm.nih.gov/pubmed/22172468 Accessed September 4,
2017.
Review:
Maresch CC, Petry SF, Theis S, Bosy-Westphal A, Linn T (2017) Low Glycemic Index Prototype Isomaltulose-Update
of Clinical Trials. Nutrients 9(4). http://www.mdpi.com/2072-6643/9/4/381 Accessed September 4, 2017.
b) Long-term benefits of Palatinose™ on body weight and body composition
References of animal studies:
Arai H, Mizuno A, Matsuo K, Fukaya M, Sasaki H, Arima H, Matsuura M, Taketani Y, Doi T, Takeda E (2004) Effect of
a novel palatinose-based liquid balanced formula (MHN-01) on glucose and lipid metabolism in male Sprague-
Dawley rats after short- and long-term ingestion. Metabolism 53(8):977–983.
http://www.ncbi.nlm.nih.gov/pubmed/15281004 Accessed September 4, 2017.
Fujiwara T, Naomoto Y, Motoki T, Shigemitsu K, Shirakawa Y, Yamatsuji T, Kataoka M, Haisa M, Egi M, Morimatsu H,
Hanazaki M, Katayama H, Morita K, Mizumoto K, Asou T, Arima H, Sasaki H, Matsuura M, Gunduz M, Tanaka N
(2007) Effects of a novel palatinose based enteral formula (MHN-01) carbohydrate-adjusted fluid diet in improving
the metabolism of carbohydrates and lipids in patients with esophageal cancer complicated by diabetes mellitus. J
Surg Res 138(2):231–240. http://www.ncbi.nlm.nih.gov/pubmed/17254607 Accessed September 4, 2017.
Sato K, Arai H, Mizuno A, Fukaya M, Sato T, Koganei M, Sasaki H, Yamamoto H, Taketani Y, Doi T, Takeda E (2007)
Dietary Palatinose and Oleic Acid Ameliorate Disorders of Glucose and Lipid Metabolism in Zucker Fatty Rats. J Nutr
137(8):1908–1915. http://jn.nutrition.org/content/137/8/1908.full.pdf Accessed September 4, 2017.
Keyhani-Nejad F, Irmler M, Isken F, Wirth EK, Beckers J, Birkenfeld AL, Pfeiffer, Andreas F H (2015) Nutritional
strategy to prevent fatty liver and insulin resistance independent of obesity by reducing glucose-dependent
insulinotropic polypeptide responses in mice. Diabetologia 58(2):374–383.
http://www.ncbi.nlm.nih.gov/pubmed/25348610 Accessed September 4, 2017.
References of human studies:
Okuno M, Kim MK, Mizu M, Mori M, Mori H, Yamori Y (2010) Palatinose-blended sugar compared with sucrose:
different effects on insulin sensitivity after 12 weeks supplementation in sedentary adults. Int J Food Sci Nutr
61(6):643–651. http://www.ncbi.nlm.nih.gov/pubmed/20367218 Accessed September 4, 2017.
September 2017
Page 10/13
Oizumi T, Daimon M, Jimbu Y, Kameda W, Arawaka N, Yamaguchi H, Ohnuma H, Sasaki H, Kato T (2007) A
palatinose-based balanced formula improves glucose tolerance, serum free fatty acid levels and body fat
composition. Tohoku J Exp Med 212(2):91–99. https://www.jstage.jst.go.jp/article/tjem/212/2/212_2_91/_pdf
Accessed September 4, 2017.
Yamori Y, Mori H, Mori M, Kashimura J, Sakamua T, Ishikawa PM, Moriguchi E, Moriguchi Y (2007) Japanese
perspective on reduction in lifestyle disease risk in immigrant japanese brazilians: a double-blind, placebo-
controlled intervention study on palatinose. Clin Exp Pharmacol Physiol 34(S5-S7).
http://onlinelibrary.wiley.com/doi/10.1111/j.1440-1681.2007.04759.x/epdf Accessed September 4, 2017.
5. Palatinose™ in sports nutrition
Palatinose™ provides the desired carbohydrate energy for physical activity in a more steady way and at the same
time promotes a higher contribution of fat oxidation in energy metabolism than commonly used readily available
carbohydrates. A higher level of fat burning is of particular interest in endurance activity where it may spare
carbohydrate sources (glycogen) for enhanced endurance. The effect of Palatinose™ on substrate utilization and fat
oxidation has been shown in a series of intervention studies which have not been published yet.
Following references are published:
König D, Zdzieblik D, Holz A, Theis S, Gollhofer A (2016) Substrate Utilization and Cycling Performance Following
Palatinose™ Ingestion: A Randomized, Double-Blind, Controlled Trial. Nutrients 8(7):390.
http://www.mdpi.com/2072-6643/8/7/390 Accessed September 4, 2017.
König D, Luther W, Poland V, Theis S, Kozianowski G, Berg A (2007) Metabolic effects of low-glycemic Palatinose™
during long lasting endurance exercise. Ann Nutr Metab 51(S1):69.
König D, Luther W, Polland V, Berg A (2007) Carbohydrates in sports nutrition impact of the glycemic index.
AgroFood Anno 18(No. 5):9–10. http://www.teknoscienze.com/agro/pdf/SPORT-KONIG.pdf Accessed September 4,
2017.
Achten J, Jentjens RL, Brouns F, Jeukendrup AE (2007) Exogenous oxidation of isomaltulose is lower than that of
sucrose during exercise in men. J Nutr 137(5):1143–1148. http://jn.nutrition.org/content/137/5/1143.full.pdf
Accessed September 4, 2017.
Review:
Maresch CC, Petry SF, Theis S, Bosy-Westphal A, Linn T (2017) Low Glycemic Index Prototype Isomaltulose-Update
of Clinical Trials. Nutrients 9(4). http://www.mdpi.com/2072-6643/9/4/381 Accessed September 4, 2017.
September 2017
Page 11/13
Research at Swansea University investigated the benefits of Palatinose™ on fat oxidation, metabolic control and
incidences of hypoglycemia during physical activity in men with type 1 diabetes mellitus, as described in the
following publications:
West DJ, Morton RD, Stephens JW, Bain SC, Kilduff LP, Luzio S, Still R, Bracken RM (2011) Isomaltulose improves
postexercise glycemia by reducing CHO oxidation in T1DM. Med Sci Sports Exerc 43(2):204–210.
https://www.ncbi.nlm.nih.gov/pubmed/20543751 Accessed September 4, 2017.
West DJ, Stephens JW, Bain SC, Kilduff LP, Luzio S, Still R, Bracken RM (2011b) A combined insulin reduction and
carbohydrate feeding strategy 30 min before running best preserves blood glucose concentration after exercise
through improved fuel oxidation in type 1 diabetes mellitus. J Sports Sci 29(3):279–289.
http://www.ncbi.nlm.nih.gov/pubmed/21154013 Accessed September 4, 2017.
Bracken RM, Page R, Gray B, Kilduff LP, West DJ, Stephens JW, Bain SC (2012) Isomaltulose improves glycemia and
maintains run performance in type 1 diabetes. Med Sci Sports Exerc 44(5):800–808.
http://www.ncbi.nlm.nih.gov/pubmed/22051571 Accessed September 4, 2017.
Campbell MD, Walker M, Trenell MI, Stevenson EJ, Turner D, Bracken RM, Shaw JA, West DJ (2014) A low-glycemic
index meal and bedtime snack prevents postprandial hyperglycemia and associated rises in inflammatory markers,
providing protection from early but not late nocturnal hypoglycemia following evening exercise in type 1 diabetes.
Diabetes Care 37:371–379. http://care.diabetesjournals.org/content/37/7/1854.full-text.pdf Accessed September
4, 2017.
Campbell MD, Walker M, Bracken RM, Turner D, Stevenson EJ, Gonzalez JT, Shaw JA, West DJ (2015) Insulin therapy
and dietary adjustments to normalize glycemia and prevent nocturnal hypoglycemia after evening exercise in type
1 diabetes: a randomized controlled trial. BMJ Open Diabetes Res Care 3(1):e000085.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4442134/pdf Accessed September 4, 2017.
6. Palatinose™ and its potential in cognitive performance and mood
Carbohydrates and their supply of glucose to the brain play a central role in cognitive performance and mood.
Palatinose™ with its steady and sustained glucose supply is of particular interest with respect to beneficial effects in
the later phase after a meal. The potential of Palatinose™ in cognitive performance and mood has been addressed
in the following studies:
Young H, Benton D (2015) The effect of using isomaltulose (Palatinose™) to modulate the glycaemic properties of
breakfast on the cognitive performance of children. Eur J Nutr 54(6):1013–1020.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540784/pdf Accessed September 4, 2017.
Young H, Benton D (2014) The glycemic load of meals, cognition and mood in middle and older aged adults with
differences in glucose tolerance: A randomized trial. e-SPEN.Journal 9(4):e147-e154.
http://www.clinicalnutritionespen.com/article/S2212-8263(14)00020-7/pdf Accessed September 4, 2017.
September 2017
Page 12/13
Dye L, Gilsenan MB, Quadt F, Martens VE, Bot A, Lasikiewicz N, Camidge D, Croden F, Lawton C (2010) Manipulation
of glycemic response with isomaltulose in a milk-based drink does not affect cognitive performance in healthy
adults. Mol Nutr Food Res 54(4):506–515. http://www.ncbi.nlm.nih.gov/pubmed/20140897 Accessed September 4,
2017.
Sekartini R, Wiguna T, Bardosono S, Novita D, Arsianti T, Calame W, Schaafsma A (2013) The effect of lactose-
isomaltulose-containing growing-up milks on cognitive performance of Indonesian children: a cross-over study. Br J
Nutr 110(6):1089–1097. http://www.ncbi.nlm.nih.gov/pubmed/23680182 Accessed September 4, 2017.
Taib MN, Shariff ZM, Wesnes KA, Saad HA, Sariman S (2012) The effect of high lactose-isomaltulose on cognitive
performance of young children. A double blind cross-over design study. Appetite 58(1):81–87.
http://www.ncbi.nlm.nih.gov/pubmed/21986189 Accessed September 4, 2017.
7. Palatinose™ is kind to teeth
Palatinose™ is no substrate for oral bacteria and therefore the first sugar that is kind to teeth. Its tooth-friendliness
has been confirmed in pH telemetry studies. A corresponding claim has been accepted a) in the USA by FDA and
implemented in the Code of Federal Regulations as well as b) in the EU following the publication of a positive EFSA
opinion.
References:
Department of Health and Human Services - Food and Drug Administration (2007) 21 CFR Part 101 [Docket No
2006P-0487] Food labeling, health claims, dietary non-cariogenic carbohydrate sweeteners and dental caries.
Federal Register Vol 72 No 179, September 17:p. 52783. http://www.fda.gov/OHRMS/DOCKETS/98fr/cf086.pdf
Accessed September 4, 2017.
EFSA Panel on Dietetic Products, Nutrition and Allergies (2011) Scientific Opinion on the substantiation of health
claims related to the sugar replacers xylitol, sorbitol, mannitol, lactitol, isomalt, erythritol, D-tagatose, isomaltulose,
sucralose and polydextrose and maintenance of tooth mineralization by decreasing tooth demineralization (…), and
reduction of post-prandial glycemic responses (…) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA
Journal 9(4):2076. http://www.efsa.europa.eu/de/efsajournal/doc/2076.pdf Accessed September 4, 2017.
8. Palatinose™ in infant and small children nutrition
Palatinose™ is suitable for infants from the age of 6 months, when complementary feeding starts. It provides
benefits to milk formula applications when used in place of maltodextrin, glucose or other high glycemic
carbohydrates as it is slowly and fully available and therefore provides a low blood glucose profile. Hence,
Palatinose™ brings the metabolic profile closer to that of mother milk. The suitability and good tolerance of
Palatinose™ have both been confirmed in a study with infants.
September 2017
Page 13/13
Reference:
Fleddermann M, Rauh-Pfeiffer A, Demmelmair H, Holdt L, Teupser D, Koletzko B (2016) Effects of a Follow-On
Formula Containing Isomaltulose (Palatinose™) on Metabolic Response, Acceptance, Tolerance and Safety in
Infants: A Randomized-Controlled Trial. PloS ONE 11(3):e0151614.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4795687/pdf Accessed September 4, 2017.
Want to know more?
In case of question or further enquiries, please, do not hesitate to contact BENEO’s Nutrition Communication team.
BENEO-Institute
c/o BENEO Inc.
6 Upper Pond Road #3A
Parsippany, NJ 07054 (USA)
Phone +1 973-867-2140
Fax
+1 973-867-2141
Email: contact@beneo.com
Web: www.beneo.com
Legal Disclaimer:
This information is presented in good faith and believed to be correct; nevertheless no responsibility/warranties as
to the completeness or accuracy of this information are taken. This information is supplied upon the condition that
the persons receiving the same will make their own determination as to its suitability for their purposes prior to use.